tm
Seeing Is Believing
tm
Seeing Is Believing
VERV is currently covered by 7 analysts with an average price target of $27.55. This is a potential upside of $20.97 (318.69%) from yesterday's end of day stock price of $6.58.
Verve Therapeutics's activity chart (see below) currently has 8 price targets and 23 ratings on display. The stock rating distribution of VERV is 68.75% BUY and 31.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 19.43 days.
Highest price target for VERV is $35, Lowest price target is $22, average price target is $27.55.
Most recent stock forecast was given by LUCA ISSI from RBC on 28-Feb-2024. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of VERV, 11 are a BUY (68.75%), 5 are a HOLD (31.25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
35
$28.42 (431.91%)
35
1 months 29 days ago
0/4 (0%)
$17.04 (94.88%)
Buy
32
$25.42 (386.32%)
29
5 months 18 days ago
0/3 (0%)
$15.25 (91.04%)
Hold
22
$15.42 (234.35%)
22
7 months 13 days ago
1/3 (33.33%)
$9 (69.23%)
8
Hold
31
$24.42 (371.12%)
48
8 months 15 days ago
0/2 (0%)
$13.02 (72.41%)
Buy
56
$49.42 (751.06%)
34
1 years 8 months 1 days ago
1/4 (25%)
$14.69 (35.56%)
128
What is VERV (Verve Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERV (Verve Therapeutics)?
Which analyst is the currently most bullish on VERV (Verve Therapeutics)?
Which analyst is the currently most reserved on VERV (Verve Therapeutics)?
